π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study will evaluate the efficacy, safety, and PK of ranibizumab 100 mi...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-17
Trial ID
NCT05562947
Treatments Being Tested
Study GR41675 is a Multicenter, Randomized Study in Participants with Diabe...
Status
Completed
Location
Barnet Dulaney Perkins Eye Center
Start Date
2020-08-10
Trial ID
NCT04503551
Treatments Being Tested
This study will assess corneal endothelial cells in participants with nAMD ...
Status
Recruiting
Location
Barnet Dulaney Perkins Eye Center
Start Date
2021-12-14
Trial ID
NCT04853251
Treatments Being Tested
Study WR42221 is a Phase IIIb, global, multicenter, randomized, visual asse...
Status
Active Not Recruiting
Location
Centro Oftalmologico Dr. Charles S.A.
Start Date
2021-07-14
Trial ID
NCT04657289
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness, safety, and PRO...
Status
Recruiting
Location
Medizinische UniversitΓ€t Innsbruck
Start Date
2025-11-27
Trial ID
NCT06847542
Treatments Being Tested
This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of...
Status
Active Not Recruiting
Location
Barnet Dulaney Perkins Eye Center
Start Date
2019-09-30
Trial ID
NCT04108156
This study will evaluate the effectiveness and safety of a 36-week refill r...
Status
Withdrawn
Location
Oftalmos
Start Date
2023-12-29
Trial ID
NCT05126966
Treatments Being Tested
The VOYAGER study is a primary data collection, non-interventional, prospec...
Status
Active Not Recruiting
Location
Retinal Research Institute, LLC
Start Date
2022-11-21
Trial ID
NCT05476926
Treatments Being Tested
Study GR40548 is a Phase III, randomized, multicenter, open-label (visual a...
Status
Completed
Location
Barnet Dulaney Perkins Eye Center
Start Date
2018-09-12
Trial ID
NCT03677934
Treatments Being Tested
This is a Phase II multicenter, dose-ranging, randomized, active treatment ...
Status
Completed
Location
Barnet Dulaney Perkins Eye Center
Start Date
2015-09-28
Trial ID
NCT02510794
Treatments Being Tested